Fibromyalgia & musculoskeletal pain

Association of fibromyalgia with cancerous and non-cancerous gastrointestinal comorbidities: a cross-sectional study

Clin Exp RheumatolPublished Retrospective cross-sectional study

Authors' conclusion

Our findings suggest that FM is positively associated with various benign but not malignant GI disorders.

Study context

Population
Subjects with FM and age- and sex-matched controls, largest health maintenance organisation in Israel (mean age 56.5 years, SD=14; 91% female)
Participants
18,598 vs 36,985
Exposure
FM vs age- and sex-matched controls
  • Fibromyalgian = 18,598
  • Controlsn = 36,985reference
Outcome
Association of FM with benign GI disorders (irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), celiac disease, Crohn's disease, ulcerative colitis) and GI malignancies (colorectal, pancreatic, stomach, liver, bile duct cancers)
Methodological detailsage- and sex-matched controls, electronic database of the largest health maintenance organisation in Israel
  • Age- and sex-matched controls
  • Electronic database of the largest health maintenance organisation in Israel

Main finding

As reported in the abstract

Each group vs controlsEstimate (95% CI)P value
Fibromyalgia
OR (IBS) 4.61(4.09–5.2)
P < 0.001
Fibromyalgia
OR (GERD) 2.62(2.5–2.75)
P < 0.001
Fibromyalgia
OR (PUD) 2.13(1.98–2.3)
P < 0.001
Fibromyalgia
OR (celiac disease) 2.08(1.63–2.65)
P < 0.001
Fibromyalgia
OR (Crohn's disease) 1.85(1.408–2.32)
P < 0.001
Fibromyalgia
OR (ulcerative colitis) 1.81(1.4–2.33)
P < 0.001

Observational data: associations, not effects.

Original publication

Association of fibromyalgia with cancerous and non-cancerous gastrointestinal comorbidities: a cross-sectional study. Clin Exp Rheumatol. Published 19 September 2022. doi:10.55563/clinexprheumatol/rp5lkn

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.